Photo from Paolo Tarantino/Twitter
Sep 10, 2023, 17:27
Paolo Tarantino: In our latest The Oncologist article led by Edoardo Crimini, we analyze geographical accessibility to NGS-informed trials in Italy
Paolo Tarantino, MD, Clinical research fellow at the Dana-Farber Cancer Institute, shared the following insight on X/Twitter:
“NGS allows to match patients to trials, but only if these are accessible. In our latest The Oncologist article led by Edoardo Crimini, we analyze geographical accessibility to NGS-informed trials in Italy, finding heterogeneous availability, but a trend toward improvement.”
For the article click here.
Source: Paolo Tarantino/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 10:38
Dec 21, 2024, 10:35
Dec 21, 2024, 10:19
Dec 21, 2024, 09:22
Dec 21, 2024, 09:06
Dec 21, 2024, 09:00
Dec 21, 2024, 08:51
Dec 21, 2024, 08:48
Dec 21, 2024, 08:42
Dec 21, 2024, 08:37